The 2019 novel coronavirus, now known as COVID-19, is a virus strain that was newly identified at the end of 2019. Health experts are concerned because little is known about this new virus and it has the potential to cause severe illness and death in some people. Read more.
As a healthcare worker, you are working diligently to care for your patients while preventing the spread of COVID-19. ASHP offers some tips for protecting your family and friends and minimizing exposure in your home. Read more.
CDC has developed interim guidance for how healthcare providers, laboratories, and public health staff should use antibody tests. Read more.
Health and Human Services has announced additional funds to be distributed to Medicaid and CHIP providers. Please see this document for the FAQ related to this additional $15 billion distribution. Learn more.
Protection and Resources
Continuing Education Opportunities Related to COVID-19
Workplace Planning Tools
Reputable Medical Societies Pages
Pharmaceutical Treatment Resources
Pharmaceutical Research Resources
Resources for Parents/Children
Governmental COVID-19 Resources
Relief Pharmacy Support Help
Is your pharmacy facing a staffing shortage due to COVID-19? KPhA is compiling lists of pharmacists, technicians and student pharmacists willing to work temporarily in various practice settings. Access the current lists (members only).
CMS Encourages Minimal Face-to-Face Contact for Medication Delivery, Dispensing
In response to the Jan. 31 declaration of a public health emergency by the Secretary of Health and Human Services and the subsequent declaration of a national emergency by the President on March 13, the Centers for Medicare and Medicaid Services (CMS) issued guidance on March 20 regarding minimizing face-to-face contact for medication delivery and dispensing.
CMS encourages Part D sponsors to work with their first tier, downstream, and related entities to identify means of ensuring that medication is delivered to patients without requiring face-to-face contact, which could result in transmission of the coronavirus.
Comments from Plans/Payers
State Price-Gouging Law Now in Effect
A Kansas law that prohibits profiteering by raising prices on items consumers find necessary because of the COVID-19 virus outbreak is in effect statewide.
The law generally prohibits unjustifiably raising prices for goods and services for which consumer demand is likely to increase because of the virus outbreak. A price increase is presumed unjustified if it exceeds by 25 percent or more the price at which the goods or services were available on March 11 or the price for which the same goods or services are available from other sellers in the trade area.
Examples of consumer goods and services governed by the anti-profiteering law include, but are not limited to, food items, sanitary and cleaning supplies such as hand sanitizer and disinfecting wipes, emergency supplies, medical supplies and services, lodging, and any other property or service for which consumer demand may increase in response to the virus outbreak. The law carries a penalty of up to $10,000 per violation.
KPhA reminds pharmacy owners and managers that if they suspect any price-gouging measures happening in relation to their purchase of pharmaceutical products from wholesalers or other sources to please contact the Attorney General's Consumer Protection Division at www.InYourCornerKansas.org or call (800) 432-2310 to request a paper complaint form be sent by mail.